Twitter LinkedIn
    Monday, May 23
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»Novo Holdings and Vivo Capital lead USD200m Series A investment in Esco Lifesciences Group
    Deals & Transactions

    Novo Holdings and Vivo Capital lead USD200m Series A investment in Esco Lifesciences Group

    June 1, 2021Updated:June 1, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Novo Holdings has co-led with Vivo Capital the over-subscribed USD200 million Series A and Crossover round in Esco Lifesciences Group (Esco), a leading provider of life sciences tools and services.

    The financing will enable Esco to strengthen its position through organic and external growth and transformation, as well as invest in China, thus addressing some of the most dynamic market segments and geographies. Other investors include two Asian sovereign wealth funds and Singapore-based global investor, EDBI.

    Esco is a world-leading manufacturer of laboratory and biopharma equipment and IVF medical devices, with four divisions, namely, Scientific, Medical, Healthcare, and Aster, which offers mission-critical equipment and advanced solutions to a broad diversity of laboratories, clinics and bio-pharma production sites in over 100 countries, thus contributing to the future of life science research and manufacturing.

    Read more at Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    deals
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Buyout Firm Bridgepoint Weighs $2 Billion Sale of Software Provider Kyriba

    May 23, 2022

    CD&R, TPG Bid $21 a Share for Animal-Health Firm Covetrus

    May 23, 2022

    Private equity moves into the antitrust spotlight

    May 23, 2022

    Chipmaker Broadcom in talks to buy VMware for up to $50bn

    May 23, 2022

    Comments are closed.

    Other Articles

    CloudNine secures growth equity investment to expand product offerigns and fund future acquisitions

    June 15, 2021

    Private equity, venture capital firms invest $598 million in Tamil Nadu

    January 4, 2021

    CVS Health launches USD100m venture fund

    May 2, 2021

    Carlyle partners with Inova in EUR60m deal

    July 1, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?